Finasteride After Hair Transplant: Benefits, Risks, FDA Label

You do not strictly need finasteride after a hair transplant, but many surgeons recommend it for men with ongoing male pattern hair loss. The reason: a transplant does not stop your native, non-transplanted hair from continuing to thin, which can make the result look worse over time (Dermatologic Surgery, 2005). In a small trial, men who took finasteride 1 mg around their transplant had more hair at 1 year than men on placebo (Leavitt 2005). Finasteride is a prescription drug with known side effects, so the choice should be made with your doctor.

What finasteride does

Finasteride blocks the enzyme that turns testosterone into DHT, the hormone that shrinks scalp hair follicles in male pattern hair loss. The ISHRS says it lowers DHT in the scalp by about two-thirds (International Society of Hair Restoration Surgery).

Under its FDA-approved label, Propecia (finasteride 1 mg) is approved for male pattern hair loss in men only. The label recommends one 1 mg tablet a day. It usually takes 3 months or more of daily use to see a benefit, and if you stop, the effect reverses within 12 months (FDA label).

In a 5-year study cited by the ISHRS, 65% of men with mild to moderate hair loss had a positive result, meaning less hair loss, regrowth, or both (ISHRS).

Why it matters after a transplant

Transplanted hairs usually keep growing. The hair around them is a different story: the trial authors note that the coverage gained from a transplant can be reduced by continued thinning and loss of the native hair (Leavitt 2005). For more on what lasts and what does not, see is a hair transplant permanent?

What the trial showed

The main study is a U.S. randomized, double-blind trial of 79 men aged 20 to 45 (Dermatologic Surgery):

• Men took finasteride 1 mg or a placebo daily, from 4 weeks before surgery until 48 weeks after.
• At 48 weeks, the finasteride group had significantly better hair counts and photo ratings.
• Visible improvement on the top and front of the scalp was seen in 94% of the finasteride group vs 67% of the placebo group.
• Finasteride was generally well tolerated.

Limits: it was a single, small, 1-year study. We found no large long-term trial of finasteride specifically after transplants. The long-term evidence comes from studies of finasteride for hair loss in general.

Side effects: what the FDA label says

In clinical trials

In three 12-month trials of men with hair loss, sexual side effects were somewhat more common with finasteride than with placebo (FDA label):

Overall, 3.8% of men on finasteride and 2.1% on placebo reported one or more of these. They went away in men who stopped the drug and in most who kept taking it (FDA label).

Reported after approval

The label also lists problems reported after the drug went on the market. Because these reports are voluntary, the FDA says their frequency and cause cannot always be reliably established (FDA label). They include:

• sexual problems that continued after stopping the drug, including erectile, libido, ejaculation and orgasm problems
• depression, suicidal thoughts and suicidal behavior
• male infertility or poor semen quality, which has improved after stopping in some reports
• breast tenderness and enlargement, male breast cancer, testicular pain, and allergic reactions

How often side effects persist after stopping is disputed. The ISHRS says the frequency of this "post-finasteride syndrome" is controversial, that most hair surgeons find it rare, and that research is ongoing (ISHRS). If you notice mood changes, tell your doctor right away.

How common are side effects in real life?

Estimates differ. The ISHRS summarizes early studies as showing sexual side effects in about 2% of men, and a 2017 study of 3,177 men as showing 0.7%. It also notes a review of 17 trials in which finasteride and dutasteride increased sexual side effects in men treated for an enlarged prostate, but not significantly in men treated for hair loss (ISHRS). Surveys of men who report persistent symptoms paint a much worse picture, which is part of the controversy (ISHRS). The honest summary: most men in trials had no sexual side effects, a small share did, and the rate of lasting problems is not known.

Other warnings

• Pregnancy. Finasteride can cause abnormal genitals in a male fetus. Women who are or may be pregnant should not handle crushed or broken tablets (FDA label).
• PSA tests. Finasteride lowers PSA, a blood test used to screen for prostate cancer. Tell any doctor who orders a PSA test that you take it (FDA label).
• High-grade prostate cancer. In a 7-year trial of a 5 mg dose in men 55 and older, high-grade prostate cancer was slightly more common on finasteride (1.8% vs 1.1%) (FDA label).
• Blood donation. The ISHRS says men taking finasteride should not donate blood (ISHRS).

What about topical finasteride?

Many clinics and telehealth companies now sell finasteride sprays or solutions, often mixed with minoxidil. The ISHRS describes topical finasteride as effective and increasingly popular (ISHRS). But the FDA says there is no FDA-approved topical finasteride. In April 2025 it warned about compounded versions after 32 adverse event reports between 2019 and 2024, including erectile dysfunction, anxiety, depression, suicidal thoughts and brain fog. Most reports said the effects continued after stopping. Some patients said they were told a topical product had no risk (FDA). Do not assume "topical" means "no side effects."

Timing and stopping

• When to start. There is no single rule. In the trial, men started 4 weeks before surgery (Leavitt 2005). Ask your surgeon whether to start before, or after the scalp has healed.
• How long. The benefit lasts only while you take it. The label says the effect reverses within 12 months of stopping (FDA label).
• Stopping. The ISHRS notes that stopping finasteride or minoxidil abruptly is usually followed by significant shedding of the hair they had preserved (ISHRS). Transplanted hair is not the hair at risk.
• Women. Propecia is not approved for women (FDA label). Women should ask about other options; see our guide to shock loss for medicines used around surgery.

Finasteride with minoxidil

Hair restoration doctors often combine finasteride with minoxidil, and the ISHRS says minoxidil can enhance finasteride's effect (ISHRS). Minoxidil is a different drug that works in a different way, and topical minoxidil is FDA-approved for hair loss in both men and women (ISHRS). It is also an option for people who cannot or do not want to take finasteride.

Questions to ask your doctor

1. Is my native hair still thinning enough that finasteride makes sense for me?
2. Should I start before surgery or after my scalp heals?
3. What side effects should make me stop and call you?
4. How will we handle PSA testing if I need it?
5. If I want to have children, does this change your advice?

If your transplant is abroad

If a clinic abroad offers finasteride or a topical mix as part of the package, before you start:

• Ask exactly what the product is, its dose, and whether it is a compounded topical.
• Get a U.S. prescriber involved, so someone at home can monitor side effects and PSA tests.
• Bring home a written medicine plan from the clinic.

Our questions to ask a hair transplant clinic and our hair transplant in Turkey guide cover the rest of the planning.

Related reading: PRP After Hair Transplant: What the Evidence Really Shows, Hair Transplant for Women: Who Qualifies and What to Expect.